These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7049073)

  • 21. Pharmacokinetics and therapeutic efficacy of imipenem, ceftazidime, and ceftriaxone in experimental meningitis due to an ampicillin- and chloramphenicol-resistant strain of Haemophilus influenzae type b.
    Sakata Y; McCracken GH; Thomas ML; Olsen KD
    Antimicrob Agents Chemother; 1984 Jan; 25(1):29-32. PubMed ID: 6322679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibilities of anaerobic bacteria to N-formimidoyl thienamycin (MK0787) and to other antibiotics.
    Kesado T; Watanabe K; Asahi Y; Isono M; Ueno K
    Antimicrob Agents Chemother; 1982 Jun; 21(6):1016-22. PubMed ID: 6956247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of imipenem in experimental group B streptococcal bacteremia and meningitis.
    Kim KS
    Chemotherapy; 1985; 31(4):304-9. PubMed ID: 3896683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [N-Formimidoyl-thienamycin in Animal Studies].
    Ritzerfeld W
    Arzneimittelforschung; 1983; 33(3):470-2. PubMed ID: 6575782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trimethoprim-sulfamethoxazole therapy of experimental Escherichia coli meningitis in rabbits.
    Mylotte JM; Bates TR; Sergeant KA; Matson RE; Beam TR
    Antimicrob Agents Chemother; 1981 Jul; 20(1):81-7. PubMed ID: 7025751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin.
    McCracken GH; Sakata Y
    Antimicrob Agents Chemother; 1985 Feb; 27(2):141-5. PubMed ID: 3845793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of ampicillin-sulbactam for treatment of experimental meningitis caused by a beta-lactamase-producing strain of Escherichia coli K-1.
    Guerra-Romero L; Kennedy SL; Fournier MA; Tureen JH; Täuber MG
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2037-41. PubMed ID: 1759824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic and bacteriological correlations between antimicrobial therapy of experimental meningitis in rabbits and meningitis in humans: a review.
    McCracken GH
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():97-108. PubMed ID: 6365874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococci.
    Auckenthaler R; Wilson WR; Wright AJ; Washington JA; Durack DT; Geraci JE
    Antimicrob Agents Chemother; 1982 Sep; 22(3):448-52. PubMed ID: 6958215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative activities of N-formimidoyl thienamycin, ticarcillin, and tobramycin against experimental Pseudomonas aeruginosa pneumonia.
    Pennington JE; Johnson CE
    Antimicrob Agents Chemother; 1982 Sep; 22(3):406-8. PubMed ID: 6814354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities.
    Kropp H; Sundelof JG; Kahan JS; Kahan FM; Birnbaum J
    Antimicrob Agents Chemother; 1980 Jun; 17(6):993-1000. PubMed ID: 6931549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of N-formimidoyl thienamycin and cephalosporins against isolates from nosocomially acquired bacteremia.
    Gutiérrez-Núñez J; Harrington PT; Ramirez-Ronda CH
    Antimicrob Agents Chemother; 1982 Mar; 21(3):509-12. PubMed ID: 6954876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits.
    Täuber MG; Shibl AM; Hackbarth CJ; Larrick JW; Sande MA
    J Infect Dis; 1987 Sep; 156(3):456-62. PubMed ID: 3302052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.
    Pusztai-Markos Z; Pranada F
    Eur J Clin Microbiol; 1982 Feb; 1(1):49-51. PubMed ID: 6293811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime.
    Verbist L; Verhaegen J
    Antimicrob Agents Chemother; 1981 Mar; 19(3):402-6. PubMed ID: 6264844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of cefotaxime, imipenem-cilastatin, ampicillin-gentamicin, and ampicillin-chloramphenicol in the treatment of experimental Escherichia coli bacteremia and meningitis.
    Kim KS
    Antimicrob Agents Chemother; 1985 Sep; 28(3):433-6. PubMed ID: 3907493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.
    Brown JE; Del Bene VE; Collins CD
    Antimicrob Agents Chemother; 1981 Feb; 19(2):248-52. PubMed ID: 6214986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of trimethoprim/sulfamethoxazole in experimental Escherichia coli bacteremia and meningitis.
    Kim KS; Anthony BF
    Chemotherapy; 1983; 29(6):428-35. PubMed ID: 6360577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
    Braveny I; Machka K; Elsser R
    Infection; 1982 Jan; 10(1):45-9. PubMed ID: 6279523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Penetration of cefotaxime and moxalactam into cerebrospinal fluid of rabbits with experimentally induced Escherichia coli meningitis.
    Nolan CM; Ulmer C
    Rev Infect Dis; 1982; 4 Suppl():S396-400. PubMed ID: 6294789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.